WEDNESDAY, Dec. 7 (Healthday News) -- In November, the U.S. Food And Drug Administration revoked its approval of the drug Avastin for the treatment of Breast Cancer. But, a new study suggests that the drug can boost the survival of women with a specific type of aggressive breast tumor when used in conjunction with two other medications. read more..
Tuesday, 13 March 2012
Food And Drug Administration-Treatment Of Breast Cancer-Healthday News-Avastin
Monday, 12 March 2012
Global Health Regulators-Supply Chain-Cancer Drug-Avastin
NEW YORK (Reuters) - As drug counterfeiters step up their sales of bogus medicines, global health regulators have few protections in place to prevent them from reaching patients, and new laws aimed at addressing the problem could be years away. Scrutiny of the supply chain has grown since fake versions of Roche's multibillion-dollar cancer drug Avastin turned up at U.S. oncology practices late last year, sparking an international investigation that so far stretches from southern California back to Turkey with a stopover in a Cairo suburb. ... read more..
Saturday, 25 February 2012
Pharmaceutical Company Roche-Public Health Officials-Counterfeit Drug-Avastin
Counterfeit versions of the cancer-fighting drug Avastin have been discovered in circulation in the United States, public health officials and the pharmaceutical company Roche warned Wednesday. read more..